Current status of lung cancer screening.
Recent results have demonstrated a major reduction in lung cancer mortality through computed tomography screening and no benefit from chest radiograph (CXR) screening. This presents a huge potential for benefit but also poses challenges regarding management of details to minimize harm. Many unresolved questions remain that must be addressed to implement computed tomography screening for lung cancer in a thoughtful and responsible way.
Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA.
Usman
U
Ahmad
Frank C
FC
Detterbeck
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging* / Q000473:pathology / Q000517:prevention & control*; D055088:Early Detection of Cancer / Q000379:methods / Q000706:statistics & numerical data*; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology / Q000517:prevention & control*; D008403:Mass Screening / Q000458:organization & administration*; D008875:Middle Aged; D009367:Neoplasm Staging; D018579:Patient Selection; D013902:Radiography, Thoracic; D018570:Risk Assessment; D015996:Survival Rate; D014057:Tomography, X-Ray Computed